These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16555123)

  • 21. Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis.
    Kurahara H; Takao S; Maemura K; Shinchi H; Natsugoe S; Aikou T
    Clin Cancer Res; 2004 Dec; 10(24):8413-20. PubMed ID: 15623620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma.
    Yang W; Klos K; Yang Y; Smith TL; Shi D; Yu D
    Cancer; 2002 Jun; 94(11):2855-61. PubMed ID: 12115372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach.
    Takahashi R; Tanaka S; Hiyama T; Ito M; Kitadai Y; Sumii M; Haruma K; Chayama K
    Oncol Rep; 2003; 10(4):797-802. PubMed ID: 12792726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
    Bachtiary B; Schindl M; Pötter R; Dreier B; Knocke TH; Hainfellner JA; Horvat R; Birner P
    Clin Cancer Res; 2003 Jun; 9(6):2234-40. PubMed ID: 12796391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
    Van der Auwera I; Van Laere SJ; Van den Eynden GG; Benoy I; van Dam P; Colpaert CG; Fox SB; Turley H; Harris AL; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2004 Dec; 10(23):7965-71. PubMed ID: 15585631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance and expression of vascular endothelial growth factor-C (VEGF-C) in esophageal squamous carcinoma and glioma].
    Pang XH; Tian H; Liu ZY; Li SM; Liu ST; Tian GP
    Ai Zheng; 2003 Nov; 22(11):1166-9. PubMed ID: 14613645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus.
    Noguchi T; Takeno S; Shibata T; Uchida Y; Yokoyama S; Müller W
    Oncol Rep; 2002; 9(5):995-9. PubMed ID: 12168062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
    Lim SC
    Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
    Acs G; Xu X; Chu C; Acs P; Verma A
    Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Roles of VEGF-C and its receptor Flt-4 in proliferation and metastasis of primary breast cancer].
    Liu F; Zhang YJ
    Ai Zheng; 2003 Oct; 22(10):1053-6. PubMed ID: 14558949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer.
    Schoppmann SF; Birner P; Studer P; Breiteneder-Geleff S
    Anticancer Res; 2001; 21(4A):2351-5. PubMed ID: 11724292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer.
    Nakashima T; Huang CL; Liu D; Kameyama K; Masuya D; Ueno M; Haba R; Yokomise H
    Med Sci Monit; 2004 Jun; 10(6):BR157-65. PubMed ID: 15173661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.
    Wu QW; She HQ; Liang J; Huang YF; Yang QM; Yang QL; Zhang ZM
    BMC Cancer; 2012 Jan; 12():47. PubMed ID: 22284579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1alpha (HIF-1alpha).
    Bos R; van Diest PJ; van der Groep P; Greijer AE; Hermsen MA; Heijnen I; Meijer GA; Baak JP; Pinedo HM; van der Wall E; Shvarts A
    Oncogene; 2003 Dec; 22(55):8948-51. PubMed ID: 14654791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review).
    Schoppmann SF; Horvat R; Birner P
    Oncol Rep; 2002; 9(3):455-60. PubMed ID: 11956609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.
    Aebersold DM; Burri P; Beer KT; Laissue J; Djonov V; Greiner RH; Semenza GL
    Cancer Res; 2001 Apr; 61(7):2911-6. PubMed ID: 11306467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphangiogenesis and tumor metastasis.
    Pepper MS; Tille JC; Nisato R; Skobe M
    Cell Tissue Res; 2003 Oct; 314(1):167-77. PubMed ID: 12883995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer.
    Shibaji T; Nagao M; Ikeda N; Kanehiro H; Hisanaga M; Ko S; Fukumoto A; Nakajima Y
    Anticancer Res; 2003; 23(6C):4721-7. PubMed ID: 14981919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of E-cadherins in development of lymphatic tumor emboli.
    Gupta A; Deshpande CG; Badve S
    Cancer; 2003 May; 97(9):2341-7. PubMed ID: 12712492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors.
    Rubbia-Brandt L; Terris B; Giostra E; Dousset B; Morel P; Pepper MS
    Clin Cancer Res; 2004 Oct; 10(20):6919-28. PubMed ID: 15501970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.